Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia

This publication has 17 references indexed in Scilit:

• Prognostic Significance of Survivin in Pediatric Acute Lymphoblastic Leukemia
  Indian Journal of Hematology and Blood Transfusion, 2011
• Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells
  Molecular Cancer Therapeutics, 2008
• Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia
  Haematologica, 2007
• Characterisation of the anti-apoptotic function of survivin-ΔEx3 during TNFα−mediated cell death
  British Journal of Cancer, 2007
• Long-Term Results of a Randomized Trial on Extended Use of High Dose l-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia
  Journal of Clinical Oncology, 2005
• Survivin as a Radioresistance Factor, and Prognostic and Therapeutic Target for Radiotherapy in Rectal Cancer
  Cancer Research, 2005
• Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
  Blood, 2003
• Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells
  The Journal of Immunology, 2003
• Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults
  Blood, 1984
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group
  British Journal of Haematology, 1976